{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:36:57Z","timestamp":1793036217499,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T00:00:00Z","timestamp":1424044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s13277-015-3214-8","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T10:16:42Z","timestamp":1424168202000},"page":"5473-5483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence"],"prefix":"10.1007","volume":"36","author":[{"given":"Eman","family":"Abdelzaher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Farouk","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,16]]},"reference":[{"issue":"2","key":"3214_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390. doi: 10.3322\/caac.20107 .","journal-title":"CA Cancer J Clin"},{"key":"3214_CR2","doi-asserted-by":"crossref","unstructured":"Hirko KA, Soliman AS, Ahmed Hablas, et al. (2013) Trends in breast cancer incidence rates by age and stage at diagnosis in Gharbiah, Egypt, over 10 years (1999\u20132008). Journal of Cancer Epidemiology, vol. 2013, Article ID 916394, 7 pages. doi: 10.1155\/2013\/916394","DOI":"10.1155\/2013\/916394"},{"key":"3214_CR3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7150\/jca.1.150","volume":"1","author":"CO Madu","year":"2010","unstructured":"Madu CO, Lu Y. Novel diagnostic biomarkers for prostate cancer. J Cancer. 2010;1:150\u201377. doi: 10.7150\/jca.1.150 .","journal-title":"J Cancer"},{"issue":"1","key":"3214_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-008-0409-0","volume":"87","author":"F Mansilla","year":"2009","unstructured":"Mansilla F, da Costa KA, Wang S, Kruh\u00f8ffer M, Lewin TM, Orntoft TF, et al. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl). 2009;87(1):85\u201397. doi: 10.1007\/s00109-008-0409-0 .","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"3214_CR5","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI38061","volume":"120","author":"JP Bridges","year":"2010","unstructured":"Bridges JP, Ikegami M, Brilli LL, Chen X, Mason RJ, Shannon JM. LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice. J Clin Invest. 2010;120(5):1736\u201348. doi: 10.1172\/JCI38061 .","journal-title":"J Clin Invest"},{"key":"3214_CR6","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1194\/jlr.D300020-JLR200","volume":"44","author":"K Ekroos","year":"2003","unstructured":"Ekroos K, Ejsing CS, Bahr U, Karas M, Simons K, et al. Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation. J Lipid Res. 2003;44:2181\u201392. doi: 10.1194\/jlr. D300020-JLR200 .","journal-title":"J Lipid Res"},{"issue":"13","key":"3214_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2091-13-8","volume":"7","author":"E Soupene","year":"2012","unstructured":"Soupene E, Kuypers FA. Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell. BMC Biochem. 2012;7(13):8. doi: 10.1186\/1471-2091-13-8 .","journal-title":"BMC Biochem"},{"issue":"9","key":"3214_CR8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1248\/bpb.b12-00243","volume":"35","author":"T1 Yamazaki","year":"2012","unstructured":"Yamazaki T1, Wakabayashi M, Ikeda E, Tanaka S, Sakamoto T, Mitsumoto A, et al. Induction of 1-acylglycerophosphocholine acyltransferase genes by fibrates in the liver of rats. Biol Pharm Bull. 2012;35(9):1509\u201315. doi: 10.1248\/bpb. b12-00243 .","journal-title":"Biol Pharm Bull"},{"key":"3214_CR9","doi-asserted-by":"crossref","unstructured":"Nakanishi H, Shindou H, Hishikawa D, Harayama T, Ogasawara R, Suwabe A, Taguchi R, Shimizu T (2006) Cloning and characterization of mouse lung-type acylCoA:lysophosphatidylcholine acyltransferase 1(LPCAT1). Expression in alveolar type II cells and possible involvement in surfactant production. J Biol Chem. 21;281(29):20140-20147. doi: 10.1074\/jbc.M600225200 .","DOI":"10.1074\/jbc.M600225200"},{"key":"3214_CR10","doi-asserted-by":"crossref","unstructured":"Lands WE (2000) Stories about acyl chains. Biochim Biophys Acta. 3;1483(1):1-14. DOI: 10.1016\/S1388-1981(99)00177-8 .","DOI":"10.1016\/S1388-1981(99)00177-8"},{"key":"3214_CR11","doi-asserted-by":"crossref","unstructured":"Soupene E, Fyrst H, Kuypers FA (2008) Mammalian acyl-CoA:lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci U S A. 8;105(1):88-93. doi: 10.1073\/pnas.0709737104 .","DOI":"10.1073\/pnas.0709737104"},{"key":"3214_CR12","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1073\/pnas.0604946103","volume":"103","author":"X Chen","year":"2006","unstructured":"Chen X, Hyatt B, Mucenski M, Mason R, Shannon J. Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells. Proc Natl Acad Sci U S A. 2006;103:11724\u20139. doi: 10.1073\/pnas.0604946103 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3214_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/JOE-07-0027","volume":"193","author":"AK Agarwal","year":"2007","unstructured":"Agarwal AK, Sukumaran S, Bartz R, Barnes RI, Garg A. Functional characterization of human 1-acylglycerol-3-phosphate-O acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity. J Endocrinol. 2007;193(3):445\u201357. doi: 10.1677\/JOE-07-0027 .","journal-title":"J Endocrinol"},{"issue":"9","key":"3214_CR14","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1194\/jlr.M800500-JLR200","volume":"50","author":"T Harayama","year":"2009","unstructured":"Harayama T, Shindou H, Shimizu T. Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J Lipid Res. 2009;50(9):1824\u201331. doi: 10.1194\/jlr. M800500-JLR200 .","journal-title":"J Lipid Res"},{"issue":"1","key":"3214_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yexmp.2011.11.001","volume":"92","author":"X Zhou","year":"2012","unstructured":"Zhou X, Lawrence TJ, He Z, Pound CR, Mao J, Bigler SA. The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer. Exp Mol Pathol. 2012;92(1):105\u201310. doi: 10.1016\/j.yexmp.2011.11.001 .","journal-title":"Exp Mol Pathol"},{"key":"3214_CR16","doi-asserted-by":"crossref","unstructured":"Kikuchi H, Uehara T, Setoguchi T, Yamamoto M, Ohta M, Kamiya K, et al. 2012 Overexpression of LPCAT1 and concomitant lipid alterations in gastric cancer. Cancer Research 72(8) .doi: 10.1158\/1538-7445.AM2012-3022 .","DOI":"10.1158\/1538-7445.AM2012-3022"},{"key":"3214_CR17","unstructured":"Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver, M.J, eds. (2012) WHO classification of tumours of the breast, IARC Press, Lyon, France, Volume 4, 4th ed."},{"issue":"5","key":"3214_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403\u201310. doi: 10.1111\/j.1365-2559.1991.tb00229 .","journal-title":"Histopathology"},{"key":"3214_CR19","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. (2010) AJCC cancer staging manual. Springer, New York, 7th ed."},{"key":"3214_CR20","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784\u201395.","journal-title":"J Clin Oncol"},{"key":"3214_CR21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118\u201345. doi: 10.1200\/JCO.2006.09.2775 .","journal-title":"J Clin Oncol"},{"issue":"9","key":"3214_CR22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1200\/JCO.1990.8.9.1483","volume":"8","author":"B Fisher","year":"1990","unstructured":"Fisher B, Brown AM, Dimitrov NV, et al. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6\u00a0months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15. J Clin Oncol. 1990;8(9):1483\u201396.","journal-title":"J Clin Oncol"},{"key":"3214_CR23","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1200\/JCO.1998.16.11.3486","volume":"16","author":"EG Mansour","year":"1998","unstructured":"Mansour EG, Gray R, Shatila AH, et al. Survival advantage of adjuvant chemotherapy in high risk node-negative breast cancer: ten year analysis\u2014an intergroup study. J Clin Oncol. 1998;16:3486\u201392.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3214_CR24","doi-asserted-by":"crossref","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","volume":"9","author":"DG Altman","year":"2012","unstructured":"Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med. 2012;9(5):e1001216. doi: 10.1371\/journal.pmed.1001216 .","journal-title":"PLoS Med"},{"key":"3214_CR25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","volume":"103","author":"M Dowsett","year":"2011","unstructured":"Dowsett M, Nielsen TO, A\u2019Hern R, Bartlett J, Coombes RC, Cuzick J, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group. J Natl Cancer Inst. 2011;103:1656\u201364. doi: 10.1093\/jnci\/djr393 .","journal-title":"J Natl Cancer Inst"},{"key":"3214_CR26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3892\/etm.2010.133","volume":"1","author":"R Nishimura","year":"2010","unstructured":"Nishimura R, Osako T, Okumura Y, Hayashi M, Toyozumi Y, et al. Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer. Exp Ther Med. 2010;1:747\u201354. doi: 10.3892\/etm.2010.133 .","journal-title":"Exp Ther Med"},{"issue":"4","key":"3214_CR27","doi-asserted-by":"crossref","first-page":"e61204","DOI":"10.1371\/journal.pone.0061204","volume":"8","author":"Y Ide","year":"2013","unstructured":"Ide Y, Waki M, Hayasaka T, Nishio T, Morita Y, et al. Human breast cancer tissues contain abundant phosphatidylcholine (36:1) with high stearoyl-CoA desaturase-1 expression. PLoS ONE. 2013;8(4):e61204. doi: 10.1371\/journal.pone.0061204 .","journal-title":"PLoS ONE"},{"key":"3214_CR28","volume-title":"Cancer incidence and mortality worldwide","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide. Lyon: IARC Press; 2013."},{"key":"3214_CR29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763\u201377. doi: 10.1038\/nrc2222 .","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3214_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/10409238.2012.735643","volume":"48","author":"ND Ridgway","year":"2013","unstructured":"Ridgway ND. The role of phosphatidylcholine and choline metabolites to cell proliferation and survival. Crit Rev Biochem Molec. 2013;48(1):20\u201338. doi: 10.3109\/10409238.2012.735643 .","journal-title":"Crit Rev Biochem Molec"},{"key":"3214_CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/157340507780619160","volume":"3","author":"F Podo","year":"2007","unstructured":"Podo F, Saradanelli F, Iorio E, Canese R, Carpinelli G, et al. Abnormal choline phospholipid metabolism in breast and ovary cancer: molecular bases for noninvasive imaging approaches. Curr Med Imag Rev. 2007;3:123\u201337. doi: 10.2174\/157340507780619160 .","journal-title":"Curr Med Imag Rev"},{"key":"3214_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01834624","volume":"20","author":"P Bougnoux","year":"1992","unstructured":"Bougnoux P, Chajes V, Lanson M, Hacene K, Body G, et al. Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat. 1992;20:185\u201394.","journal-title":"Breast Cancer Res Treat"},{"key":"3214_CR33","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-10-3894","volume":"71","author":"M Hilvo","year":"2011","unstructured":"Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S, et al. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res. 2011;71:3236\u201345. doi: 10.1158\/0008-5472.CAN-10-3894 .","journal-title":"Cancer Res"},{"key":"3214_CR34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biochi.2010.08.001","volume":"93","author":"D Mauvoisin","year":"2011","unstructured":"Mauvoisin D, Mounier C. Hormonal and nutritional regulation of SCD1 gene expression. Biochimie. 2011;93:78\u201386. doi: 10.1016\/j.biochi.2010.08.001 .","journal-title":"Biochimie"},{"key":"3214_CR35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-012-2354-4","volume":"137","author":"AM Holder","year":"2013","unstructured":"Holder AM, Gonzalez-Angulo AM, Chen H, Akcakanat A, Do KA, et al. High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients. Breast Cancer Res Treat. 2013;137:319\u201327. doi: 10.1007\/s10549-012-2354-4 .","journal-title":"Breast Cancer Res Treat"},{"key":"3214_CR36","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1073\/pnas.0712245105","volume":"105","author":"D Hishikawa","year":"2008","unstructured":"Hishikawa D, Shindou H, Kobayashi S, Nakanishi H, Taguchi R, et al. Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc Natl Acad Sci U S A. 2008;105:2830\u20135. doi: 10.1073\/pnas.0712245105 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3214_CR37","doi-asserted-by":"crossref","unstructured":"Ellis B, Kaercher L, Snavely C, Zhao Y (2012) Lipopolysaccharide triggers nuclear import of Lpcat1 to regulate inducible gene expression in lung epithelia. Chunbin ZouWorld J Biol Chem 26; 3(7): 159-166. doi: 10.4331\/wjbc.v3.i7.159 .","DOI":"10.4331\/wjbc.v3.i7.159"},{"issue":"6","key":"3214_CR38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molonc.2013.07.009","volume":"7","author":"K Grupp","year":"2013","unstructured":"Grupp K, Sanader S, Sirma H, Simon R, et al. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers. Online Molec Oncol. 2013;7(6):1001\u201311. doi: 10.1016\/j.molonc.2013.07.009 .","journal-title":"Online Molec Oncol"},{"key":"3214_CR39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrc2795","volume":"10","author":"ID Davis","year":"2010","unstructured":"Davis ID, Birrell SN, et al. Breast and prostate cancer: more similar than different. Nat Rev Cancer. 2010;10:205\u201312. doi: 10.1038\/nrc2795 .","journal-title":"Nat Rev Cancer"},{"key":"3214_CR40","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl","key":"3214_CR41","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1194\/jlr.R800035-JLR200","volume":"50","author":"H Shindou","year":"2009","unstructured":"Shindou H, Hishikawa D, Harayama T, Yuki K, Shimizu T. Recent progress on acyl CoA: lysophospholipid acyltransferase research. J Lipid Res. 2009;50(Suppl):S46\u201351. doi: 10.1194\/jlr. R800035-JLR200 .","journal-title":"J Lipid Res"},{"key":"3214_CR42","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1074\/jbc.M710422200","volume":"283","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Chen YQ, Bonacci TM, Bredt DS, Li S, et al. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. J Biol Chem. 2008;283:8258\u201365. doi: 10.1074\/jbc.M710422200 .","journal-title":"J Biol Chem"},{"key":"3214_CR43","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1158\/0008-5472.CAN-07-5547","volume":"68","author":"AS Cheng","year":"2008","unstructured":"Cheng AS, Culhane AC, Chan MW, Venkataramu CR, Ehrich M, et al. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res. 2008;68:1786\u201396. doi: 10.1158\/0008-5472.CAN-07-5547 .","journal-title":"Cancer Res"},{"key":"3214_CR44","doi-asserted-by":"crossref","first-page":"26122","DOI":"10.1074\/jbc.M702854200","volume":"282","author":"S Yoon","year":"2007","unstructured":"Yoon S, Lee MY, Park SW, Moon JS, Koh YK, et al. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem. 2007;282:26122\u201331. doi: 10.1074\/jbc.M702854200 .","journal-title":"J Biol Chem"},{"key":"3214_CR45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/dmm.015040","volume":"7","author":"L McDonald","year":"2014","unstructured":"McDonald L, Ferrari N, Terry A, Bell M, Mohammed ZM, Cl O, et al. RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland. Dis Model Mech. 2014;7:525\u201334. doi: 10.1242\/dmm.015040 .","journal-title":"Dis Model Mech"},{"key":"3214_CR46","first-page":"255","volume":"6","author":"K Jorgensen","year":"2001","unstructured":"Jorgensen K, Hoyrup P, Pedersen TB, Mouritsen OG. Dynamical and structural properties of lipid membranes in relation to liposomal drug delivery systems. Cell Mol Biol Lett. 2001;6:255\u201363.","journal-title":"Cell Mol Biol Lett"},{"key":"3214_CR47","doi-asserted-by":"crossref","first-page":"e6812","DOI":"10.1371\/journal.pone.0006812","volume":"4","author":"N Scaglia","year":"2009","unstructured":"Scaglia N, Chisholm JW, Igal RA. Inhibition of stearoylcoa desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS ONE. 2009;4:e6812. doi: 10.1371\/journal.pone.0006812 .","journal-title":"PLoS ONE"},{"key":"3214_CR48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-007-9556-1","volume":"107","author":"I Soerjomataram","year":"2008","unstructured":"Soerjomataram I, Louwman MWJ, et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008;107:309\u201330. doi: 10.1007\/s10549-007-9556-1 .","journal-title":"Breast Cancer Res Treat"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3214-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3214-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3214-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:20:18Z","timestamp":1566346818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3214-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,16]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3214"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3214-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,16]]}}}